Paper40868931
A Comprehensive Review of the Role of Rho-Kinase Inhibitors in Corneal Diseases.
Leong EYX and 8 others. Life (Basel), 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. A Comprehensive Review of the Role of Rho-Kinase Inhibitors in Corneal Diseases. Papers, record 40868931. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40868931
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References150
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19907920 | Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity. | Cell Mol Life Sci | 2010 | https://conductscience.org/library/papers/19907920 | PubMed |
| 2 | 35993293 | Rho-kinase inhibitors: Role in corneal endothelial disorders. | Semin Ophthalmol | 2023 | https://conductscience.org/library/papers/35993293 | PubMed |
| 3 | 18085464 | Immune mechanisms of corneal allograft rejection. | Curr Eye Res | 2007 | https://conductscience.org/library/papers/18085464 | PubMed |
| 4 | 38479724 | Rho-kinase inhibitor alleviates CD4+T cell mediated corneal graft rejection by modulating its STAT3 and STAT5 activation. | Exp Eye Res | 2024 | https://conductscience.org/library/papers/38479724 | PubMed |
| 5 | 20478312 | Sonic hedgehog induces angiogenesis via Rho kinase-dependent signaling in endothelial cells. | J Mol Cell Cardiol | 2010 | https://conductscience.org/library/papers/20478312 | PubMed |
| 6 | 40120926 | Ripasudil does not induce phospholipid accumulation in human corneal epithelial cells. | Exp Eye Res | 2025 | https://conductscience.org/library/papers/40120926 | PubMed |
| 7 | 15548136 | PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation. | Biochem J | 2005 | https://conductscience.org/library/papers/15548136 | PubMed |
| 8 | 38689101 | The Protective Effect of Rho-Associated Kinase Inhibitor Eye Drops (Ripasudil) on Corneal Endothelial Cells After Cataract Surgery: A Prospective Comparative Study. | Ophthalmol Ther | 2024 | https://conductscience.org/library/papers/38689101 | PubMed |
| 9 | 22898649 | Corneal neovascularization: an anti-VEGF therapy review. | Surv Ophthalmol | 2012 | https://conductscience.org/library/papers/22898649 | PubMed |
| 10 | 25823914 | The effects of Rho-associated kinase inhibitor Y-27632 on primary human corneal endothelial cells propagated using a dual media approach. | Sci Rep | 2015 | https://conductscience.org/library/papers/25823914 | PubMed |
| 11 | 32672669 | Once-Daily Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure in the Randomized Phase 3 MERCURY-2 Study. | Ophthalmol Glaucoma | 2019 | https://conductscience.org/library/papers/32672669 | PubMed |
| 12 | 30098200 | The Corneal Basement Membranes and Stromal Fibrosis. | Invest Ophthalmol Vis Sci | 2018 | https://conductscience.org/library/papers/30098200 | PubMed |
| 13 | 36637659 | Fuchs Dystrophy and Cataract: Diagnosis, Evaluation and Treatment. | Ophthalmol Ther | 2023 | https://conductscience.org/library/papers/36637659 | PubMed |
| 14 | 23462749 | The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23462749 | PubMed |
| 15 | 33859757 | Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension. | Theranostics | 2021 | https://conductscience.org/library/papers/33859757 | PubMed |
| 16 | 25811020 | Aqueous cytokines as predictors of macular edema in patients with diabetes following uncomplicated phacoemulsification cataract surgery. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25811020 | PubMed |
| 17 | 35150417 | Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Patients with Glaucoma or Ocular Hypertension over 24 Months. | Adv Ther | 2022 | https://conductscience.org/library/papers/35150417 | PubMed |
| 18 | 35037906 | Honeycomb Epithelial Edema Associated With Rho Kinase Inhibition: A Case Series and Review of the Literature. | Cornea | 2022 | https://conductscience.org/library/papers/35037906 | PubMed |
| 19 | 30386798 | Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature. | Med Hypothesis Discov Innov Ophthalmol | 2018 | https://conductscience.org/library/papers/30386798 | PubMed |
| 20 | 39730553 | Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor. | Sci Rep | 2024 | https://conductscience.org/library/papers/39730553 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42593179 | Targeting RhoA/ROCK Signaling to Modulate Extracellular Matrix Remodeling in Corneal Endothelial Dystrophies. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42593179 | PubMed |
| 41669778 | Emerging in vitro models of corneal stromal fibrosis: Toward human-relevant platforms for anti-scarring therapeutics. | Indian J Ophthalmol | 2026 | https://conductscience.org/library/papers/41669778 | PubMed |
| 41313356 | Exploring corneal endothelial cell dynamics: structure, functions and therapeutic approaches. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/41313356 | PubMed |
| 40943853 | RhoKinase (ROCK) Inhibition as a Therapeutic Strategy for Pseudophakic Bullous Keratopathy: A Comprehensive Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/40943853 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ROCK1 | 6093 | PubTator's text mining | https://conductscience.org/library/genes/6093 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40868931
GET https://conductscience.org/api/papers/v1/40868931/references?page=2